Calcium-Phosphorus Regulation Therapy on Heart Valve Disease

Clinical trial NCT06660524 · RECRUITING

Trial details

NCT number: NCT06660524
Sponsor: China National Center for Cardiovascular Diseases
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Degenerative Heart Valve Disease Heart Valve Calcification Chronic Kidney Disease(CKD)Calcium-Phosphorus Metabolism Disorders

Start date: 2024-03-01
Primary completion: 2025-06-01
Enrollment: 196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.